Passage BIO PASG
NASDAQ PASG
$4.12 -0.08 (-1.93%)
At close: Oct 2, 2026 · 4:00 PM EDT

Passage BIO (PASG) Return on Capital Employed [ROCE] (2020 - 2026)

Updated

Passage BIO (PASG) recorded Return on Capital Employed [ROCE] of -386.38% in Q2 2026, down 288.03 percentage points from -98.35% a year earlier and down 246.00 percentage points from the prior quarter.

Analysis

Passage BIO (PASG) Return on Capital Employed [ROCE] (2020 - 2026) Analysis & Trends

For FY2025, Passage BIO reported Return on Capital Employed [ROCE] of -83.18%, down 17.46 percentage points from FY2024.

  • Annual Return on Capital Employed [ROCE] has declined for three straight years, with a five-year change of -34.54 percentage points (FY2020 to FY2025).
  • Across earlier years, Return on Capital Employed [ROCE] came in at -65.72% in FY2024 (-5.74 pp), -59.98% in FY2023 (-10.72 pp), -49.26% in FY2022 (+10.26 pp) and -59.52% in FY2021 (-10.88 pp).
  • The Q2 2026 figure is the lowest quarterly Return on Capital Employed [ROCE] in data going back to Q1 2020.
  • On a year-over-year basis, Return on Capital Employed [ROCE] has declined for 22 consecutive quarters, with an average year-over-year change of -55.25 percentage points over the last eight quarters.
  • The year-over-year drop in Return on Capital Employed [ROCE] has ranged between 0.28 percentage points (Q3 2024) and 288.03 percentage points (Q2 2026) over the last five years.
  • Per Business Quant, the preceding three quarters came in at -140.37% (Q1 2026), -109.21% (Q4 2025) and -91.34% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 17.83%
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 17.92%
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn 19.32%
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn 9.54%
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 16.66%
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn -5.97%
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 11.86%
10 Passage BIO 13.90 Mn 13.90 Mn - -386.38%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -386.38%
Mar 31, 2026 -140.37%
Dec 31, 2025 -109.21%
Sep 30, 2025 -91.34%
Jun 30, 2025 -98.35%
Mar 31, 2025 -90.08%
Dec 31, 2024 -80.26%
Sep 30, 2024 -73.39%
Jun 30, 2024 -68.46%
Mar 31, 2024 -68.24%
Dec 31, 2023 -75.50%
Sep 30, 2023 -73.11%
Jun 30, 2023 -63.75%
Mar 31, 2023 -62.26%
Dec 31, 2022 -58.04%
Sep 30, 2022 -61.31%
Jun 30, 2022 -62.55%
Mar 31, 2022 -59.88%
Dec 31, 2021 -54.07%
Sep 30, 2021 -44.18%
API Access

Passage BIO Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=PASG&period=max&api_key=YOUR_API_KEY